Proposition of standardized protocol for photodynamic therapy for vulvar lichen sclerosus

J Dermatolog Treat. 2022 Feb;33(1):560-568. doi: 10.1080/09546634.2020.1771260. Epub 2020 Jun 1.

Abstract

Background: Photodynamic therapy (PDT) is an alternative treatment modality for vulvar lichen sclerosus (VLS) which is a chronic inflammatory mucosal condition. In literature, no consensus of optimal parameters of PDT for VLS is reached so far.

Objectives: The aim of this narrative review is to develop a standardized treatment protocol for PDT in VLS.

Methods: A systematic literature search was conducted to identify studies reporting on PDT in VLS and used treatment parameters, side-effects, and clinical outcomes were summarized.

Results: Thirteen studies used 5-aminolevulinic acid (5-ALA) with concentrations of 20%, 10%, 5% and three studies used methyl aminolevulinate (MAL). Generally, the light source was red light (median 630 nm). Light dose varied between 9 and 180 J/cm2 and light intensity between 40 and 700 mW/cm2. Incubation period with the photosensitizer ranged from 2 to 6 h. All studies showed a substantial improvement in VLS-related pruritus, burning and pain.

Conclusions: Based on a literature review, we suggest the following protocol for PDT in VLS: 5% 5-ALA as a photosensitizer applied for 3 h under occlusion before irradiation at the dose of 120 J/cm2 with red light (590-760 nm) and intensity of 204 mW/cm2.

Keywords: Protocol; photodynamic therapy (PDT); vulvar lichen sclerosus.

MeSH terms

  • Aminolevulinic Acid / therapeutic use
  • Humans
  • Pain / drug therapy
  • Photochemotherapy*
  • Photosensitizing Agents / therapeutic use
  • Pruritus / drug therapy
  • Review Literature as Topic
  • Vulvar Lichen Sclerosus* / drug therapy

Substances

  • Photosensitizing Agents
  • Aminolevulinic Acid